ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.65B
Enterprise Value 32.06B
Trailing P/E N/A
Forward P/E 1-16.75
PEG Ratio (5 yr expected) 1-0.52
Price/Sales (ttm)933.62
Price/Book (mrq)9.27
Enterprise Value/Revenue 3727.68
Enterprise Value/EBITDA 6-16.48

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-4,445.49%

Management Effectiveness

Return on Assets (ttm)-41.26%
Return on Equity (ttm)-76.78%

Income Statement

Revenue (ttm)2.84M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-62.90%
Gross Profit (ttm)4.86M
EBITDA -125.27M
Net Income Avi to Common (ttm)-131.39M
Diluted EPS (ttm)-4.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)255.29M
Total Cash Per Share (mrq)7.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.85
Book Value Per Share (mrq)6.88

Cash Flow Statement

Operating Cash Flow (ttm)-108.41M
Levered Free Cash Flow (ttm)-63.71M

Trading Information

Stock Price History

Beta 0.96
52-Week Change 3126.80%
S&P500 52-Week Change 315.75%
52 Week High 369.00
52 Week Low 321.95
50-Day Moving Average 358.69
200-Day Moving Average 342.29

Share Statistics

Avg Vol (3 month) 3195.27k
Avg Vol (10 day) 3102.41k
Shares Outstanding 541.52M
Float 18.87M
% Held by Insiders 124.93%
% Held by Institutions 144.38%
Shares Short 3344.86k
Short Ratio 32.9
Short % of Float 30.00%
Shares Short (prior month) 3329.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A